Skip to main content
Equibles
EMBC logo

EMBC · Embecta Corp. · Metrics

Track EMBC — free

Use EMBC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EMBC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.71 -0.15 (-2.19%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$380.19M
Shares
56.66M
Volume · Oct 23 717.05K Avg daily vol (3M) 1.28M

EMBC metrics

113 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.71
Market cap
$380.19M

Price action

20 metrics
Price change (1W)
+7.0%
Price change (30D)
+13.7%
Price change (3M)
+104.0%
Price change (6M)
-27.2%
Price change (YTD)
-43.5%
Price change (1Y)
-52.5%
Trailing year
Price change (5Y)
—
52-week high
$14.64
52-week low
$2.90
Change from 52-week high
-54.2%
Change from 52-week low
+131.4%
Annualized volatility
81.5%
Annualized volatility (3M)
76.0%
Beta
0.5
RSI (14D)
67.4
Price vs SMA 50
+19.7%
Price vs SMA 200
+1.8%
Avg volume (3M)
1.28M
Relative volume
0.6
Average dollar volume
$6.56M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
56.66M

Valuation

12 metrics
P / E (TTM)
4.6
Trailing earnings · reciprocal yield 21.9%
PEG ratio
—
EV / revenue
1.6×
reciprocal yield 62.9%
EV / EBITDA
6.1×
reciprocal yield 16.5%
EV / EBIT
7.3×
reciprocal yield 13.8%
P / sales
0.4×
reciprocal yield 267.9%
P / book
—
FCF yield
43.3%
TTM · current market cap
Buyback yield
—
P / FCF
2.3
reciprocal yield 43.3%
P / operating cash flow
2.2
reciprocal yield 45.8%
Earnings yield
23.0%

Historical valuation

8 metrics
P / E historical average (3Y)
12.0×
reciprocal yield 8.3%
P / E historical average (5Y)
12.4×
reciprocal yield 8.1%
EV / revenue historical average (3Y)
1.9×
reciprocal yield 53.2%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.4%
EV / EBIT historical average (3Y)
10.8×
reciprocal yield 9.3%
EV / EBIT historical average (5Y)
10.8×
reciprocal yield 9.3%
EV / EBITDA historical average (3Y)
8.9×
reciprocal yield 11.2%
EV / EBITDA historical average (5Y)
9.2×
reciprocal yield 10.9%

Dividends & buybacks

7 metrics
Dividend yield
4.8%
Trailing 12 months
Payout ratio
31.1%
Shareholder yield
7.2%
Dividend / share (TTM)
$0.32
Dividend growth YoY
-46.7%
Dividend growth streak
0
Last ex-dividend
2026-08-27

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
59.0%
Operating margin
21.9%
Trailing 12 months
Net margin
8.6%
Gross profit (TTM)
$601.30M
Operating profit (TTM)
$223.50M
Net income (TTM)
$87.50M
Trailing 12 months
Diluted EPS (TTM)
$1.47
FCF margin
16.2%
Effective tax rate
30.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$17.19
Gross profit per diluted share (TTM)
$10.14
Operating profit per diluted share (TTM)
$3.77
EBITDA per diluted share (TTM)
$4.51
Net income per diluted share (TTM)
$1.48
Operating cash flow per diluted share (TTM)
$2.93
Free cash flow per diluted share (TTM)
$2.77
Capital expenditures per diluted share (TTM)
$0.16
R&D per diluted share (TTM)
$0.34
Stock compensation per diluted share (TTM)
$0.43
Book value per share
$-11.12

Growth

11 metrics
Revenue growth YoY
-8.1%
Year over year
Net income growth YoY
-53.6%
Revenue (TTM)
$1.02B
Trailing 12 months
EPS growth YoY
-53.8%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
-1.5%
Revenue CAGR (5Y)
-0.1%
EPS CAGR (3Y)
-25.3%
EPS CAGR (5Y)
-26.4%
FCF CAGR (3Y)
-22.3%
FCF CAGR (5Y)
-16.8%

Quality

14 metrics
Return on equity
—
Return on assets
6.9%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$267.70M
Free cash flow (TTM)
$164.60M
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
4.6
Return on invested capital
24.9%
Trailing 12 months
Net cash
−$1.24B
Latest balance sheet
Cash & equivalents
$214.70M
Total assets
$1.27B
Total debt
$1.46B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$174.10M
Capital expenditures (TTM)
$9.50M
R&D (TTM)
$20.20M
SG&A (TTM)
$319.30M
Stock compensation (TTM)
$25.30M
R&D / revenue
2.0%
Stock compensation / revenue
2.5%

Ownership (13F)

9 metrics
13F filers
323
13F filer change QoQ
-19
Institutional ownership
89.0%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
39.1%
Private-fund adviser ownership
32.2%
Active holders' share change QoQ
-16.1%
Holder tenure
10.4
Price vs estimated holder cost
-78.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.4%

Short interest

3 metrics
Short interest
10.3%
Latest settlement · 5.4 days to cover
Days to cover
5.4d
Short-squeeze score
81 / 100

Insider activity

2 metrics
Net insider buying (90D)
$520,974
Insider-sentiment score
92 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1872789 CUSIP 29082K105 13F (30d) 75 filings 71 filers Visit website Investor relations